Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 14

Zeitschriftenartikel

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2022): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational new drugs, Bd. 40: S. 163-171 [PDF, 1MB]

Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2022): Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276 [PDF, 1MB]

Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad (2022): Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study. In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509 [PDF, 294kB]

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational new drugs, Bd. 39: S. 1189-1196 [PDF, 586kB]

Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2021): Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition. In: European journal of nuclear medicine and molecular imaging [PDF, 848kB]

Stoleriu, Mircea Gabriel; Gerckens, Michael; Ströh, Katja; Kovács, Julia; Samm, Nicole; Obereisenbuchner, Florian; Hetrodt, Justin; Schmidt, Felicitas Maria; Reinmuth, Niels; Heiß-Neumann, Marion; Stacher-Priehse, Elvira; Koch, Ina; Behr, Jürgen; Ketscher, Christian; Grützner, Uwe und Hatz, Rudolf (2021): Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave. In: Pneumologie, Bd. 75, Nr. 12: S. 960-970

Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Ruehle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational New Drugs, Bd. 39, Nr. 4: S. 1189-1196

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting. In: Cancers, Bd. 13, Nr. 7, 1613

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171

Unterrainer, Marcus; Taugner, Julian; Kasmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2021): Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy +/- immune checkpoint inhibition. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 4: S. 1407-1416

Reinmuth, Niels; Bitzer, Michael; Deschler-Baier, Barbara; Fischer, Jürgen R.; Kuon, Jonas; Leipe, Jan; Rawluk, Justyna; Schulz, Christian; Heussel, Claus Peter und Schultheiss, Michael (2019): Nebenwirkungsmanagement in der Immunonkologie. Praktische Aspekte im Management immunvermittelter Nebenwirkungen unter immunonkologischer Therapie. In: Deutsche Medizinische Wochenschrift, Bd. 144, Nr. 5: S. 346-353

Hassel, Jessica C.; Heinzerling, Lucie; Aberle, Jens; Bähr, Oliver; Eigentler, Thomas K.; Grimm, Marc-Oliver; Grünwald, Victor; Leipe, Jan; Reinmuth, Niels; Tietze, Julia K.; Trojan, Jörg; Zimmer, Lisa und Gutzmer, Ralf (2017): Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions. In: Cancer Treatment Reviews, Bd. 57: S. 36-49 [PDF, 559kB]

Eigentler, Thomas K.; Hassel, Jessica C.; Berking, Carola; Aberle, Jens; Bachmann, Oliver; Grünwald, Viktor; Kähler, Katharina C.; Loquai, Carmen; Reinmuth, Niels; Steins, Martin; Zimmer, Lisa; Sendl, Anna und Gutzmer, Ralf (2016): Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy. In: Cancer Treatment Reviews, Bd. 45: S. 7-18

Dickgreber, Nicolas; Huber, Rudolf M.; Reck, Martin; Reinmuth, Niels; Schütte, Wolfgang; Serke, Monika und Wolf, Jürgen (2010): Aktuelle Entwicklungen und Perspektiven zielgerichteter Therapien. In: Onkologie, Nr. 5: S. 2-11 [PDF, 653kB]

Diese Liste wurde am Sat Mar 23 23:11:19 2024 CET erstellt.